Skip to main content

Together we are beating cancer

Donate now

HPV test

Showing 10 out of 10 results
Sânziana Foia in the lab with an image of Papcup, the new HPV test she has designed for cervical screening, on a laptop.

Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part.  Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part. 

by Sadaf Shafaghmotlagh | Analysis | 4 September 2024

4 September 2024

Squamous epithelial cells of human cervix under the microscope view.
  • Health & Medicine
  • Science & Technology

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

by Jacob Smith | In depth | 17 June 2024

17 June 2024

Stained cervical cells viewed under the microscope

22-28 January is Cervical Cancer Prevention Week. To recognise that, we’ve compiled some of our most useful content on cervical cancer, from research in the lab to screening in the clinic, to get you up to date on how we can prevent cervical cancer. 22-28 January is Cervical Cancer Prevention Week. To recognise that, we’ve compiled some of our most useful content on cervical cancer, from research in the lab to screening in the clinic, to get you up to date on how we can prevent cervical cancer.

by Jacob Smith | Analysis | 22 January 2024

22 January 2024

Scientist preparing microscope slides with liquid based cytology method for pap smear test. Cervical cancer concept.

A new study funded by Cancer Research UK has revealed a gap in many women’s understanding of HPV (human papillomavirus) and its role in cervical screening. A new study funded by Cancer Research UK has revealed a gap in many women’s understanding of HPV (human papillomavirus) and its role in cervical screening.

by Sophie Wedekind | News | 25 October 2023

25 October 2023

A bottle containing the HPV vaccine

From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back. From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.

by Lilly Matson | In depth | 21 November 2022

21 November 2022

Testing women for HPV first to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer a year in England. Testing women for HPV first to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer a year in England.

by Cancer Research UK | News | 14 June 2013

14 June 2013

Cancer Research UK logo

Testing for the human papillomavirus (HPV) as part of cervical screening reduces the number of women unnecessarily going on for further tests by over a third, new research shows today. Testing for the human papillomavirus (HPV) as part of cervical screening reduces the number of women unnecessarily going on for further tests by over a third, new research shows today.

by British Journal of Cancer | News | 28 September 2011

28 September 2011

Cancer Research UK logo

Doing the human papillomavirus (HPV) test twice with a short interval between tests would reduce the number of women having unnecessary treatment, new research shows. Doing the human papillomavirus (HPV) test twice with a short interval between tests would reduce the number of women having unnecessary treatment, new research shows.

by British Journal of Cancer | News | 24 August 2011

24 August 2011

Cancer Research UK logo

Women who have had the human papillomavirus (HPV) vaccine could need only two HPV screening tests for the rest of their lives according to new calculations being presented at the NCRI Cancer Conference in Liverpool. Women who have had the human papillomavirus (HPV) vaccine could need only two HPV screening tests for the rest of their lives according to new calculations being presented at the NCRI Cancer Conference in Liverpool.

by The National Cancer Research Institute (NCRI) | News | 10 November 2010

10 November 2010